Radiographic joint space width in the fingers of patients with rheumatoid arthritis of less than one year's duration

2006 ◽  
Vol 54 (5) ◽  
pp. 1440-1443 ◽  
Author(s):  
Ewan C. Goligher ◽  
Jeffrey Duryea ◽  
Matthew H. Liang ◽  
Frederick Wolfe ◽  
Axel Finckh
2016 ◽  
Vol 3 (4) ◽  
pp. 044502 ◽  
Author(s):  
Olga Schenk ◽  
Yinghe Huo ◽  
Koen L. Vincken ◽  
Mart A. van de Laar ◽  
Ina H. H. Kuper ◽  
...  

2016 ◽  
Vol 89 (1062) ◽  
pp. 20150967 ◽  
Author(s):  
Yohei Ono ◽  
Rina Kashihara ◽  
Nobutoshi Yasojima ◽  
Hideki Kasahara ◽  
Yuka Shimizu ◽  
...  

2020 ◽  
Vol 22 (1) ◽  
Author(s):  
Alexander Pfeil ◽  
Anica Nussbaum ◽  
Diane M. Renz ◽  
Tobias Hoffmann ◽  
Ansgar Malich ◽  
...  

Abstract Background The reduction of finger joint space width (JSW) in patients with rheumatoid arthritis (RA) is strongly associated with joint destruction. Treatment with certolizumab pegol (CZP), a PEGylated anti-TNF, has been proven to be effective in RA patients. The computer-aided joint space analysis (CAJSA) provides the semiautomated measurement of joint space width at the metacarpal-phalangeal joints (MCP) based on hand radiographs. The aim of this post hoc analysis of the RAPID 1 trial was to quantify MCP joint space distance (JSD-MCP) measured by CAJSA between baseline and week 52 in RA patients treated with certolizumab pegol (CZP) plus methotrexate (MTX) compared with MTX/placebo. Methods Three hundred twenty-eight patients were included in the post hoc analysis and received placebo plus MTX, CZP 200 mg plus MTX and CZP 400 mg plus MTX. All patients underwent X-rays of the hand at baseline and week 52 as well as assessment of finger joint space narrowing of the MCP using CAJSA (Version 1.3.6; Sectra; Sweden). The joint space width (JSW) was expressed as mean joint space distance of the MCP joints I to V (JSD-MCPtotal). Results The MTX group showed a significant reduction of joint space of − 4.8% (JSD-MCPtotal), whereas in patients treated with CZP 200 mg/MTX and CZP 400 mg/MTX a non-significant change (JSD-MCPtotal + 0.6%) was observed. Over 52 weeks, participants with DAS28 remission (DAS28 ≤ 2.6) exhibited a significant joint space increase of + 3.3% (CZP 200 mg plus MTX) and + 3.9% (CZP pegol 400 mg plus MTX). Conclusion CZP plus MTX did not reduce JSD-MCPtotal estimated by CAJSA compared with MTX/placebo. Furthermore, clinical remission (DAS28 ≤ 2.6) in patients treated with CZP plus MTX was associated with an increasing JSD, indicating radiographic remission in RA.


2016 ◽  
Vol 63 (10) ◽  
pp. 2177-2186 ◽  
Author(s):  
Yinghe Huo ◽  
Koen L. Vincken ◽  
Desiree van der Heijde ◽  
Maria J. H. De Hair ◽  
Floris P. Lafeber ◽  
...  

Diagnostics ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 147
Author(s):  
Daniel B. Abrar ◽  
Christoph Schleich ◽  
Miriam Frenken ◽  
Stefan Vordenbäumen ◽  
Jutta Richter ◽  
...  

Background: Even though cartilage loss is a known feature of psoriatic (PsA) and rheumatoid arthritis (RA), research is sparse on its role in the pathogenesis of PsA, its potential use for disease monitoring and for differentiation from RA. We therefore assessed the use of delayed gadolinium-enhanced magnetic resonance imaging of cartilage (dGEMRIC) to evaluate biochemical cartilage changes in metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints in PsA patients and compared these to RA patients. Materials and Methods: A total of 17 patients with active PsA and 20 patients with active RA were evaluated by high-resolution 3 Tesla dGEMRIC using a dedicated 16-channel hand coil. Images were analyzed by two independent raters for dGEMRIC indices and joint space width (JSW) at MCP and PIP joint levels. Results: No significant differences of dGEMRIC values could be found between both study populations (PsA 472.25 ms, RA 461.11 ms; p = 0.763). In all RA and most PsA patients, PIP joints showed significantly lower dGEMRIC indices than MCP joints (RA: D2: p = 0.009, D3: p = 0.008, D4: p = 0.002, D5: p = 0.002; PsA: D3: p = 0.001, D4: p = 0.004). Most joint spaces had similar widths in both disease entities and no significant differences were found. Conclusions: As evaluated by dGEMRIC, the molecular composition of the MCP and PIP joint cartilage of PsA patients is similar to that of RA patients, demonstrating the scientific and clinical feasibility of compositional magnetic resonance (MR) imaging in these disease entities. Patterns and severity of compositional cartilage degradation of the finger joints may therefore be assessed beyond mere morphology in PsA and RA patients.


2013 ◽  
Vol 41 (12) ◽  
pp. 2553-2564 ◽  
Author(s):  
Andrew J. Burghardt ◽  
Chan Hee Lee ◽  
Daniel Kuo ◽  
Sharmila Majumdar ◽  
John B. Imboden ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document